Patents by Inventor John Kulesza

John Kulesza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200038338
    Abstract: Provided are methods for long term drug delivery by tattoo. The bioactive agent, which comprises the drug, is delivered to a layer, or multiple layers, of the skin. Such a method allows for long-term drug activity the bioactive agent has a longer residence time within the skin when compared to routine delivery methods. Moreover, the bioactive agent may also be combined and mixed with a coloring composition, which signals the amount of bioactive agent that has been administered and if a reapplication of the bioactive agent is necessary. Also described are methods of utilizing such a drug delivery mechanism in order to effect cosmetic changes, such as enhancing hair growth by utilizing bioactive agents suited for enabling hair growth.
    Type: Application
    Filed: August 1, 2019
    Publication date: February 6, 2020
    Inventors: Carlos Wambier, John Kulesza
  • Patent number: 7763264
    Abstract: A topical composition for controlling the metabolism and/or distribution of subcutaneous fat and/or moderating the appearance of cellulite, comprising, as an active ingredient, phosphatidylcholine together with a solvent operative to maintain the phosphatidylcholine in solution, and a buffer which maintains the composition in the range of pH 7.5-9.0. Typically, the composition includes less than 10% by weight water. The composition may include further active ingredients such as xanthines. Also disclosed are methods for using the composition.
    Type: Grant
    Filed: April 21, 2006
    Date of Patent: July 27, 2010
    Inventor: John Kulesza
  • Publication number: 20060258624
    Abstract: A topical composition for controlling the metabolism and/or distribution of subcutaneous fat and/or moderating the appearance of cellulite, comprising, as an active ingredient, phosphatidylcholine together with a solvent operative to maintain the phosphatidylcholine in solution, and a buffer which maintains the composition in the range of pH 7.5-9.0. Typically, the composition includes less than 10% by weight water. The composition may include further active ingredients such as xanthines. Also disclosed are methods for using the composition.
    Type: Application
    Filed: April 21, 2006
    Publication date: November 16, 2006
    Inventor: John Kulesza